Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
A role of NR4A2 in Graves’ disease: regulation of Th17/Treg
This study aimed to explore the molecular pathogenesis of Graves’ disease (GD).
-
Article
Increased chemokine (C–C motif) ligand 21 expression and its correlation with osteopontin in Graves’ disease
Graves’ disease (GD) is a chronic autoimmune process characterized by the production of auto-antibodies that presumably consequent to the lymphocytic infiltrates in the thyroid. Chemokine (C–C motif) ligand 21...
-
Article
Circulating microRNA predicts insensitivity to glucocorticoid therapy in Graves’ ophthalmopathy
Glucocorticoid (GC) insensitivity occurs commonly in Graves’ ophthalmopathy (GO), and GC therapy is associated with major adverse effects. A reliable and easily accessible biomarker is required to predict the ...